RESETTABLE-PRESSURE HYDROCEPHALIC SHUNT W/REMOTE READOUT

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$49,717.00
Award Year:
1991
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Award Id:
16775
Agency Tracking Number:
16775
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Frontier Technology Inc (Currently FRONTIER TECHNOLOGY INC.)
530 E Montecito St #105, Santa Barbara, CA, 93103
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
William Elliot
(805) 965-2477
Business Contact:
() -
Research Institution:
n/a
Abstract
THE ULTIMATE OBJECTIVE OF THIS EFFORT IS TO DEVELOP A HYDROCEPHALIC SHUNT THAT INCORPORATES A RESETTABLE-PRESSURE VALVE MECHANISM AND AN INTRACRANIAL PRESSURE (ICP) SENSOR WITH REMOTE READ-OUT DISPLAY. THE PURPOSE FOR THIS DEVICE IS TO PROVIDE NEUROSURGEONS WITH A SHUNT THAT CAN BE ADJUSTED AT ANY TIME SO AS TO IMPROVE DEGREE OF CONTROL OVERTHE ICP, AND THEREBY IMPROVE THE QUALITY OF HEALTH CARE. IN ADDITION, THE REMOTE READ-OUT FEATURE ENABLES THE NEUROSURGEON (OR HEALTH CARE WORKER) TO MONITOR THE PATIENT'S ICP ON A REGULAR AND/OR LONG-TERM BASIS. THIS FEATURE MAY BE DEVELOPED INDEPENDENTLY FOR APPLICATIONS NOT REQUIRING SHUNTING OF THE CEREBROSPINAL FLUID, SUCH AS MONITORING THE ICP IN A PATIENT WITH A BRAIN TUMOR. THE DESIGN CONCEPT WILL BE REFINED BY THE PRINCIPAL INVESTIGATOR IN CONJUNCTION WITH THE DIRECTOR OF R&D FOR HELIX MEDICAL UNDER THE PHASE I EFFORT. HELIX WILL DEVELOP A BENCH-TEST AND EVALUATION. A "FORM-FIT" VERSION IS PLANNED FOR PHASE II, WHICH WILL UNDERGO ANIMAL TESTS. IT IS ESTIMATED THAT THERE WOULD BE A MARKET FOR OVER 100,000 OF THESE DEVICES PER YEAR. THE ULTIMATE OBJECTIVE OF THIS EFFORT IS TO DEVELOP A HYDROCEPHALIC SHUNT THAT INCORPORATES A RESETTABLE-PRESSURE VALVE MECHANISM AND AN INTRACRANIAL PRESSURE (ICP) SENSOR WITH REMOTE READ-OUT DISPLAY. THE PURPOSE FOR THIS DEVICE IS TO PROVIDE NEUROSURGEONS WITH A SHUNT THAT CAN BE ADJUSTED AT ANY TIME SO AS TO IMPROVE DEGREE OF CONTROL OVERTHE ICP, AND THEREBY IMPROVE THE QUALITY OF HEALTH CARE. IN ADDITION, THE REMOTE READ-OUT FEATURE ENABLES THE NEUROSURGEON (OR HEALTH CARE WORKER) TO MONITOR THE PATIENT'S ICP ON A REGULAR AND/OR LONG-TERM BASIS. THIS FEATURE MAY BE DEVELOPED INDEPENDENTLY FOR APPLICATIONS NOT REQUIRING SHUNTING OF THE CEREBROSPINAL FLUID, SUCH AS MONITORING THE ICP IN A PATIENT WITH A BRAIN TUMOR. THE DESIGN CONCEPT WILL BE REFINED BY THE PRINCIPAL INVESTIGATOR IN CONJUNCTION WITH THE DIRECTOR OF R&D FOR HELIX MEDICAL UNDER THE PHASE I EFFORT. HELIX WILL DEVELOP A BENCH-TEST AND EVALUATION. A "FORM-FIT" VERSION IS PLANNED FOR PHASE II, WHICH WILL UNDERGO ANIMAL TESTS. IT IS ESTIMATED THAT THERE WOULD BE A MARKET FOR OVER 100,000 OF THESE DEVICES PER YEAR.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government